Medical teams rushed to Andhra village as child dies, over 70 fall ill after malaria tablets
Source Entity
Sreenivas Janyala
A medical camp in Andhra Pradesh's Gollaguppa village led to the hospitalization of 52 people and the death of a seven-year-old girl following the distribution of anti-malaria chloroquine tablets. Chief Minister N. Chandrababu Naidu has ordered an inquiry as authorities work to stabilize the affected patients.
Medical Crisis in Polavaram: Adverse Reactions to Anti-Malaria Distribution
A distressing medical incident has unfolded in Gollaguppa village, located in the Polavaram district of Andhra Pradesh, where a routine health initiative aimed at curbing malaria resulted in a significant public health emergency. On September 1, 2026, local health officials conducted a medical camp to distribute anti-malaria chloroquine tablets. Shortly after administration, 52 of the 71 villagers who received the medication began exhibiting alarming symptoms, including severe vomiting and respiratory distress.
The Human Toll and Immediate Response
Tragically, the incident resulted in the death of a seven-year-old girl, identified as Madivi Jamuna. The scale of the reaction necessitated an urgent logistical response, with 29 individuals, including 23 Koya children under the age of ten, being transferred to the Bhadrachalam Area Hospital in neighboring Telangana for advanced care. The remaining affected villagers were stabilized at the Lakshmipuram Primary Health Centre. According to Polavaram District Collector K. Dinesh Kumar, those currently hospitalized are considered to be out of immediate danger, though the situation remains under close observation.
Government Intervention and Administrative Inquiry
Andhra Pradesh Chief Minister N. Chandrababu Naidu has taken direct oversight of the situation. Following reports of the adverse reactions, the Chief Minister held emergency consultations with senior officials from the Health and Medical Department and the district administration. His primary directive has been to ensure that all victims receive comprehensive medical treatment, while simultaneously initiating a formal inquiry to determine the cause of the mass adverse reaction.
Understanding the Context of Malaria Prevention
Chloroquine remains a standard medication for the prevention and treatment of malaria in many regions; however, its administration in mass-distribution camps requires stringent adherence to protocols regarding dosage and patient screening. The fact that a large cohort of children—47 of the 52 affected were minors—fell ill simultaneously suggests a potential breakdown in either the quality control of the medication, the administration process, or the screening for pre-existing contraindications among the village population.
Broader Implications for Rural Public Health
This incident highlights the precarious nature of rural healthcare delivery in remote regions like the Polavaram district. While medical camps are essential for controlling endemic diseases like malaria, the lack of immediate emergency stabilization facilities often forces authorities to cross state lines, as seen with the transfer of patients to Telangana. This highlights a critical need for strengthening local primary healthcare infrastructure to handle acute drug reactions without the delay of inter-state transfers.
Future Outlook and Policy Recommendations
As the investigation proceeds under the direction of the Chief Minister, the findings will likely lead to a mandatory review of drug distribution protocols across Andhra Pradesh. Future trends in public health will necessitate more rigorous pharmacological oversight during mass outreach programs. Ensuring that such tragedies are not repeated will require both technical accountability regarding the medication used and a re-evaluation of the clinical oversight provided during village-level medical camps.